Adar1 Capital Management, LLC Bridge Bio Pharma, Inc. Transaction History
Adar1 Capital Management, LLC
- $500 Billion
- Q4 2024
A detailed history of Adar1 Capital Management, LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 678,857 shares of BBIO stock, worth $25.9 Million. This represents 3.72% of its overall portfolio holdings.
Number of Shares
678,857
Previous 1,448,470
53.13%
Holding current value
$25.9 Million
Previous $36.9 Billion
49.49%
% of portfolio
3.72%
Previous 6.0%
Shares
5 transactions
Others Institutions Holding BBIO
# of Institutions
326Shares Held
178MCall Options Held
12.8MPut Options Held
2.51M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$965 Million44.98% of portfolio
-
Viking Global Investors LP25.1MShares$960 Million2.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.9MShares$569 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$476 Million0.01% of portfolio
-
State Street Corp Boston, MA6.18MShares$236 Million0.01% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $5.67B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...